Comprehensive new YouGov poll reveals majority in the UK would donate organs and blood for research and allow use of DNA and personal data to help advance healthcare
Survey shows huge pride in Britain’s history of innovation in healthcare and calls for Britain to maintain its lead
Fleming and Lister...
Responding to a new House of Commons Health and Social Care Select Committee report ‘Brexit – Medicines, Medical Devices and Substances of Human Origin’, the trade associations representing the UK's pharmaceutical and biotech industries have issued a joint response backing the Committee's...
UK Marketing Authorisation Holders urged to register with SecurMed UK
The ABPI have responded today to an announcement by the Department of Health & Social Care who have published a 12 week consultation seeking views from interested parties on the recommendations in the Cost-Effectiveness Methodology for Immunisation Programmes and Procurement (CEMIPP).
On Wednesday 21 February, Health and Social Care Secretary Jeremy Hunt announced that Baroness Julia Cumberlege will lead a review into how the NHS responds to safety concerns raised by patients about medicines or medical devices.
Today, ABPI has published the latest information giving details of ‘transfers of value’ made to healthcare organisations and healthcare professionals by pharmaceutical companies.
The ABPI Board today announces that William Harbage QC will be relinquishing his position as Chair of the PMCPA Appeal Board to focus on his private practice as a leading Silk specialising in criminal and regulatory law.
The Government has today published new guidance on a system of quarantine for people coming into the UK, subject to some exemptions.
Public Health England has published its evidence review of dependence and withdrawal problems associated with five commonly prescribed classes of medicines in England.
In a week where the Office of Health Economics (OHE) has published a report on the ten most important medicines over the life of the NHS, Dr Sheuli Porkess outlines how the pharmaceutical industry takes a substance from molecule to medicine and how the process requires persistance.